Jogender Tushir-Singh

Title(s)Associate Professor, MED: Medical Microbiology & Imm
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer. Cell Death Differ. 2023 Nov; 30(11):2408-2431. Mondal T, Gaur H, Wamba BEN, Michalak AG, Stout C, Watson MR, Aleixo SL, Singh A, Condello S, Faller R, Leiserowitz GS, Bhatnagar S, Tushir-Singh J. PMID: 37838774; PMCID: PMC10657439.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle. Microbiol Spectr. 2022 02 23; 10(1):e0236421. Mondal T, Shivange G, Habieb A, Tushir-Singh J. PMID: 35138160; PMCID: PMC8826744.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors. Cell Rep. 2021 11 02; 37(5):109953. Shivange G, Mondal T, Lyerly E, Bhatnagar S, Landen CN, Reddy S, Kim J, Doan B, Riddle P, Tushir-Singh J. PMID: 34731630; PMCID: PMC8720280.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    4. Arming "old guards" with "new dual-targeting weapons". Cancer Cell. 2021 05 10; 39(5):604-606. Lum LG, Tushir-Singh J. PMID: 33974858.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. Bispecific antibodies for the treatment of breast cancer. Expert Opin Biol Ther. 2022 08; 22(8):1017-1027. Dillon PM, Tushir-Singh J, Lum LG. PMID: 33896311; PMCID: PMC8576064.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    6. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. EMBO Mol Med. 2021 03 05; 13(3):e12716. Mondal T, Shivange GN, Tihagam RG, Lyerly E, Battista M, Talwar D, Mosavian R, Urbanek K, Rashid NS, Harrell JC, Bos PD, Stelow EB, Stack MS, Bhatnagar S, Tushir-Singh J. PMID: 33587338; PMCID: PMC7933954.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    7. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer. Cancer Res. 2020 11 01; 80(21):4791-4804. Przanowski P, Lou S, Tihagam RD, Mondal T, Conlan C, Shivange G, Saltani I, Singh C, Xing K, Morris BB, Mayo MW, Teixeira L, Lehmann-Che J, Tushir-Singh J, Bhatnagar S. PMID: 32855208; PMCID: PMC7731897.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    8. Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody. J Vis Exp. 2020 05 16; (159). Shivange G, Mondal T, Lyerly E, Gatesman J, Tushir-Singh J. PMID: 32478720.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    9. Targeting HER2 beyond breast cancer. Mol Cell Oncol. 2019; 6(3):1571984. Bhatnagar S, Tushir-Singh J. PMID: 31131305; PMCID: PMC6512921.
      View in: PubMed   Mentions: 1  
    10. A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer. Cancer Cell. 2018 08 13; 34(2):331-345.e11. Shivange G, Urbanek K, Przanowski P, Perry JSA, Jones J, Haggart R, Kostka C, Patki T, Stelow E, Petrova Y, Llaneza D, Mayo M, Ravichandran KS, Landen CN, Bhatnagar S, Tushir-Singh J. PMID: 30107179; PMCID: PMC6404966.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    11. Pharmacological reactivation of inactive X-linked Mecp2 in cerebral cortical neurons of living mice. Proc Natl Acad Sci U S A. 2018 07 31; 115(31):7991-7996. Przanowski P, Wasko U, Zheng Z, Yu J, Sherman R, Zhu LJ, McConnell MJ, Tushir-Singh J, Green MR, Bhatnagar S. PMID: 30012595; PMCID: PMC6077728.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    12. In Vitro Assay to Study Histone Ubiquitination During Transcriptional Regulation. Methods Mol Biol. 2017; 1507:235-244. Tushir-Singh J, Bhatnagar S. PMID: 27832544.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    13. Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy. Expert Opin Biol Ther. 2017 03; 17(3):325-338. Tushir-Singh J. PMID: 27977315.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    Jogender's Networks
    Concepts (70)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _